Pneumonia recovery phase (COVID-19, Omicron)
Conditions
Interventions
Control group:Qingjin Yiqi Granules in low dose+ rehabilitation treatments
Treatment group:Qingjin Yiqi Granules + rehabilitation treatments
Sponsors
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who meet the diagnostic and discharge criteria for COVID-19, and who have been negative for 2019-nCoV nucleic acid test after discharge. 2) Pediatric patients are less than or equal to 14 years; adult patients are older than 14years. 3) Patient informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who have undergone operations that affect lung function, such as lung transplantation, lung resection, lung volume reduction, etc; 2) Patients who rely on mechanical ventilation to maintain lung function, such as ventilators; 3) Combined with chronic lung diseases that affect lung function, such as severe chronic obstructive pulmonary disease; 4) Patients complicated with diseases affecting cardiac function, such as patients with heart failure and pacemakers, etc; 5) Accompanied by severe underlying diseases, such as uncontrolled heart, kidney, digestive, hematologic, neuropsychiatric, immune, metabolic diseases of clinical significance, malignant tumor, and severe malnutrition, etc; 6) Resting heart rate > 120/min; 7) Systolic blood pressure > 180mmhg or diastolic blood pressure > 100mmhg; 8) Patients with unstable angina pectoris or myocardial infarction within the last one month; 9) Severe obesity (BMI > 30kg/m2); 10) Allergic constitution, allergic to the drug components involved in the treatment program; 11) Pregnant or lactating women; 12) patients who are participating in other clinical trials; 13) patients with enrollment complexity or poor compliance, which will affect the evaluation of effect and safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Borg score;Number of squats in 30 seconds;2019-nCoV nucleic acid test;Chest CT scan;WHO-5 score;GAD-7 score;Individual symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| tongue change;Immunoinflammatory index;Pulmonary function test; | — |
Countries
China
Contacts
Public ContactHuang Yuhong
Outcome results
None listed